463 related articles for article (PubMed ID: 19952936)
21. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors.
Vang R; Kempson RL
Am J Surg Pathol; 2002 Jan; 26(1):1-13. PubMed ID: 11756764
[TBL] [Abstract][Full Text] [Related]
22. Myxoid mixed low-grade endometrial stromal sarcoma and smooth muscle tumor of the uterus. Case report.
Dundr P; Fischerová D; Povýšil C; Cibula D; Zikán M
Cesk Patol; 2012 Apr; 48(2):103-6. PubMed ID: 22716064
[TBL] [Abstract][Full Text] [Related]
23. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
Amada S; Nakano H; Tsuneyoshi M
Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
[TBL] [Abstract][Full Text] [Related]
24. [Highly cellular leiomyoma of uterus: a comparative morphologic and immunohistochemical study of endometrial stromal tumors].
Liao X; Wang Y; Yue C; Liu Y; Wang H; Dai L; Hui Y
Zhonghua Bing Li Xue Za Zhi; 2002 Oct; 31(5):396-400. PubMed ID: 12485478
[TBL] [Abstract][Full Text] [Related]
25. Mixed endometrial stromal and smooth muscle tumors of the uterus: a clinicopathologic study of 15 cases.
Oliva E; Clement PB; Young RH; Scully RE
Am J Surg Pathol; 1998 Aug; 22(8):997-1005. PubMed ID: 9706980
[TBL] [Abstract][Full Text] [Related]
26. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
[TBL] [Abstract][Full Text] [Related]
27. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases.
Dionigi A; Oliva E; Clement PB; Young RH
Am J Surg Pathol; 2002 May; 26(5):567-81. PubMed ID: 11979087
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemistry as a diagnostic aid in the interpretation of unusual mesenchymal tumors of the uterus.
Devaney K; Tavassoli FA
Mod Pathol; 1991 Mar; 4(2):225-31. PubMed ID: 1710807
[TBL] [Abstract][Full Text] [Related]
29. The importance of CD10 and h-Caldesmon in the distinction of smooth muscle tumors of the uterus and endometrial stromal sarcoma.
Saraydaroglu O; Ozuysal S; Kasap M; Ozerkan K
Saudi Med J; 2008 Sep; 29(9):1349-50. PubMed ID: 18813428
[No Abstract] [Full Text] [Related]
30. The phosphatidylinositol 3' kinase-Akt-mammalian target of rapamycin pathway in smooth muscle tumors of the uterus: selected protein expression patterns and their clinicopathologic implications.
Fadare O; Renshaw I; Olson SJ; Liang SX
Int J Gynecol Pathol; 2011 May; 30(3):244-51. PubMed ID: 21464729
[TBL] [Abstract][Full Text] [Related]
31. Transgelin, a Novel Marker of Smooth Muscle Differentiation, Effectively Distinguishes Endometrial Stromal Tumors from Uterine Smooth Muscle Tumors.
Tawfik O; Rao D; Nothnick WB; Graham A; Mau B; Fan F
Int J Gynecol Obstet Reprod Med Res; 2014 Sep; 1(1):26-31. PubMed ID: 26023684
[TBL] [Abstract][Full Text] [Related]
32. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.
Bartosch C; Exposito MI; Lopes JM
Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclooxygenase-2, c-kit, progesterone and estrogen receptors in uterine smooth muscle tumors: differential diagnosis.
Comunoğlu NU; Durak H; Comunoğlu C; Ekici AI; Ozkan F; Akyildiz EU; Ilvan S; Calay Z; Molinas N
APMIS; 2007 Jun; 115(6):726-35. PubMed ID: 17550381
[TBL] [Abstract][Full Text] [Related]
35. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
Petrović D; Babić D; Forko JI; Martinac I
Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
[TBL] [Abstract][Full Text] [Related]
36. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(4):427-34. PubMed ID: 16220232
[TBL] [Abstract][Full Text] [Related]
37. Myogenic markers in the evaluation of embryonal botryoid rhabdomyosarcoma of the female genital tract.
Riedlinger WF; Kozakewich HP; Vargas SO
Pediatr Dev Pathol; 2005; 8(3):355-61. PubMed ID: 16010486
[TBL] [Abstract][Full Text] [Related]
38. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
[TBL] [Abstract][Full Text] [Related]
39. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
[TBL] [Abstract][Full Text] [Related]
40. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
Mittal K; Demopoulos RI
Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
